{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:29:21Z","timestamp":1784914161001,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pbb.2023.173658","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T16:26:54Z","timestamp":1696523214000},"page":"173658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-\u03b3"],"prefix":"10.1016","volume":"233","author":[{"given":"Talita","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getulio Nicola","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Nunes","family":"Krum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix Alexandre Antunes","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-0144","authenticated-orcid":false,"given":"Roselei","family":"Fachinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2023.173658_bb0005","first-page":"417","article-title":"Sex differences in schizophrenia","volume":"22","author":"Abel","year":"2010"},{"key":"10.1016\/j.pbb.2023.173658_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbr133","article-title":"Is the acute NMDA receptor hypofunction a valid model of schizophrenia?","volume":"38","author":"Adell","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pbb.2023.173658_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archpsyc.1996.01830050061010","article-title":"Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients","volume":"53","author":"Akbarian","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0020","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopsych.2014.07.022","article-title":"N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia","volume":"77","author":"Anticevic","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brainresbull.2018.03.006","article-title":"Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2023.173658_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0043-119127","article-title":"Morin pretreatment attenuates schizophrenia-like behaviors in experimental animal models","volume":"68","author":"Ben-Azu","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biopha.2018.06.057","article-title":"Probable mechanisms involved in the antipsychotic-like activity of morin in mice","volume":"105","author":"Ben-Azu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbb.2023.173658_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.intimp.2019.02.052","article-title":"Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia","volume":"70","author":"Ben-Azu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2023.173658_bb0050","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s11011-022-01075-5","article-title":"Taurine, an essential \u03b2-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative\/nitrergic imbalances, and suppression of COX-2\/iNOS immunoreactions in mice","volume":"37","author":"Ben-Azu","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pbb.2023.173658_bb0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s11064-022-03808-5","article-title":"Reversal and preventive pleiotropic mechanisms involved in the antipsychotic-like effect of taurine, an essential \u03b2-amino acid in ketamine-induced experimental schizophrenia in mice","volume":"48","author":"Ben-Azu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/1098-2396(20000901)37:3<205::AID-SYN4>3.0.CO;2-A","article-title":"Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists","volume":"37","author":"Berridge","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2023.173658_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-3-4","article-title":"Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette\u2019s","volume":"3","author":"Berridge","year":"2005","journal-title":"BMC Biol."},{"key":"10.1016\/j.pbb.2023.173658_bb0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2023.173658_bb0075","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1073\/pnas.89.6.2115","article-title":"Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene","volume":"89","author":"Bu","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pbb.2023.173658_bb0080","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1523\/JNEUROSCI.22-14-06218.2002","article-title":"Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization","volume":"22","author":"Capper-Loup","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2023.173658_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.schres.2016.04.044","article-title":"Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia","volume":"175","author":"Ceretta","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2018.01.003","article-title":"Gabapentin reduces haloperidol-induced vacuous chewing movements in mice","volume":"166","author":"Ceretta","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173658_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/595141","article-title":"Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents","volume":"2012","author":"Chatterjee","year":"2012","journal-title":"ISRN Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","article-title":"Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice","volume":"63","author":"Chatterjee","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.schres.2018.02.049","article-title":"Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia","volume":"199","author":"Cheng","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.04.018","article-title":"Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia","volume":"38","author":"Chindo","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0115","first-page":"49","article-title":"PPAR-\u03b3 agonists for the treatment of major depression: a review","volume":"50","author":"Colle","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.pbb.2023.173658_bb0125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0091-3057(97)00248-7","article-title":"Psychopharmacological distinction between novel full-efficacy \u201cD1-like\u201d dopamine receptor agonists","volume":"58","author":"Deveney","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173658_bb0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jphp.13039","article-title":"Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-like behaviours and oxidative parameters in experimental animal models","volume":"71","author":"Dias","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jnr.20122","article-title":"GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia","volume":"76","author":"Dracheva","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.pbb.2023.173658_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.124","article-title":"Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis","volume":"7","author":"Egerton","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mehy.2013.03.013","article-title":"A serotonin hypothesis of schizophrenia","volume":"80","author":"Eggers","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pbb.2023.173658_bb0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/FBP.0b013e328331b9bf","article-title":"Antidepressant-like effects of rosiglitazone, a PPAR\u03b3 agonist, in the rat forced swim and mouse tail suspension tests","volume":"20","author":"Eissa Ahmed","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0155","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","article-title":"Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter","volume":"31","author":"Fachinetto","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00213-007-0831-y","article-title":"Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats","volume":"194","author":"Fachinetto","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0165","doi-asserted-by":"crossref","first-page":"107334","DOI":"10.1016\/j.neuropharm.2018.09.009","article-title":"Dissociated features of social cognition altered in mouse models of schizophrenia: focus on social dominance and acoustic communication","volume":"159","author":"Faure","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0170","author":"Feinstein"},{"key":"10.1016\/j.pbb.2023.173658_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00702-014-1257-4","article-title":"Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice","volume":"122","author":"Figueira","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2023.173658_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopsych.2021.02.009","article-title":"Altered parvalbumin basket cell terminals in the cortical visuospatial working memory network in schizophrenia","volume":"90","author":"Fish","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-015-4118-4","article-title":"Behavioral and neurochemical effects induced by reserpine in mice","volume":"233","author":"de Freitas","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.fct.2018.05.062","article-title":"Silymarin recovers 6-hydroxydopamine-induced motor deficits in mice","volume":"118","author":"de Freitas","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.pbb.2023.173658_bb0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients","volume":"83","author":"de la Fuente-Sandoval","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0205","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.pbb.2023.173658_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.apha.2020.02.005","article-title":"Ketamine for depression clinical issues","volume":"89","author":"Iqbal","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2023.173658_bb0220","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0225","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.biopsych.2012.06.021","article-title":"Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia","volume":"72","author":"Joshi","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2023.173658_bb0230","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/nprot.2007.367","article-title":"Analyzing grooming microstructure in neurobehavioral experiments","volume":"10","author":"Kalueff","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.pbb.2023.173658_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2023.173658_bb0240","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbb.2023.173658_bb0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2017.06.027","article-title":"Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia","volume":"193","author":"Koh","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pbb.2023.173658_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","article-title":"Hippocampal interneurons are abnormal in schizophrenia","volume":"131","author":"Konradi","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0260","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pbb.2011.09.006","article-title":"Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents","volume":"100","author":"Kotagale","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173658_bb0265","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awl386","article-title":"Volume, neuron density and total neuron number in five subcortical regions in schizophrenia","volume":"130","author":"Kreczmanski","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2023.173658_bb0270","doi-asserted-by":"crossref","first-page":"113293","DOI":"10.1016\/j.jep.2020.113293","article-title":"Kava decreases the stereotyped behavior induced by amphetamine in mice","volume":"265","author":"Krum","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0280","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0006-3223(99)00061-X","article-title":"Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia","volume":"46","author":"Lewis","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0285","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1111\/bph.13222","article-title":"Ketamine and phencyclidine: the good, the bad and the unexpected","volume":"172","author":"Lodge","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0290","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2023.173658_bb0295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neulet.2006.09.079","article-title":"An organic selenium compound attenuates apomorphine-induced stereotypy in mice","volume":"410","author":"Machado","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.pbb.2023.173658_bb0300","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41380-020-0711-y","article-title":"GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513","volume":"26","author":"Marques","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0310","article-title":"Chronic ketamine reduces the peak frequency of gamma oscillations in mouse prefrontal cortex ex vivo","volume":"4","author":"McNally","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pbb.2023.173658_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1515-3","article-title":"Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer\u2019s disease by restoring microglial function via a PPAR-\u03b3-dependent mechanism","volume":"16","author":"Medrano-Jim\u00e9nez","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2023.173658_bb0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00127-018-1501-6","article-title":"Recent advances in the prevention of mental disorders","volume":"53","author":"Mendelson","year":"2018","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.pbb.2023.173658_bb0325","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pbb.2023.173658_bb0330","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00213-023-06344-4","article-title":"Nano-hesperetin attenuates ketamine-induced schizophrenia-like symptoms in mice: participation of antioxidant parameters","volume":"240","author":"Moghaddam","year":"2023","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2023.173658_bb0335","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psychres.2018.04.036","article-title":"Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia","volume":"265","author":"Mohammadi","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0345","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molbrainres.2003.11.004","article-title":"Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia","volume":"121","author":"Mueller","year":"2004","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamapsychiatry.2014.3176","article-title":"Abnormalities in hemispheric specialization of caudate nucleus connectivity in schizophrenia","volume":"72","author":"Mueller","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0355","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2023.173658_bb0360","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","article-title":"The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia","volume":"48","author":"Na","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0365","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1476-5381.1995.tb15106.x","article-title":"Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia","volume":"116","author":"Noda","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0370","doi-asserted-by":"crossref","first-page":"172547","DOI":"10.1016\/j.ejphar.2019.172547","article-title":"Ketamine applications beyond anesthesia \u2013 a literature review","volume":"860","author":"Nowacka","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0375","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-211-73574-9_34","article-title":"Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia","author":"Nudmamud-Thanoi","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.pbb.2023.173658_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115432","article-title":"Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis","volume":"295","author":"Omeiza","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0385","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11033-021-06264-6","article-title":"Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice","volume":"48","author":"Oshodi","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.pbb.2023.173658_bb0390","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.08.017","article-title":"Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice","volume":"141","author":"Ossato","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2023.173658_bb0400","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","article-title":"A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders","volume":"71","author":"Pedersen","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0405","first-page":"3","article-title":"Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra","author":"Perez-Costas","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0410","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s11064-016-1961-6","article-title":"Alteration of cytokines levels in the striatum of rats: possible participation in vacuous chewing movements induced by Antipsycotics","volume":"41","author":"Peroza","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0415","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.pbb.2023.173658_bb0420","doi-asserted-by":"crossref","first-page":"105397","DOI":"10.1016\/j.nbd.2021.105397","article-title":"Ketamine\u2019s schizophrenia-like effects are prevented by targeting PTP1B","volume":"155","author":"Qin","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2023.173658_bb0425","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1734-1140(12)70879-4","article-title":"Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia","volume":"64","author":"Rao","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2023.173658_bb0430","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0435","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-020-01923-0","article-title":"Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis","author":"Reinheimer","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0440","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/026988110401800303","article-title":"Receptor mechanisms in the treatment of schizophrenia","volume":"18","author":"Reynolds","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2023.173658_bb0445","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2013 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2023.173658_bb0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"11","author":"Robinson","year":"1986","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pbb.2023.173658_bb0455","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/1389450111314070002","article-title":"Therapeutic prospects of PPARs in psychiatric disorders: a comprehensive review","volume":"14","author":"Rolland","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pbb.2023.173658_bb0460","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ab.2010.02.036","article-title":"Reversible Ponceau staining as a loading control alternative to actin in Western blots","volume":"401","author":"Romero-Calvo","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pbb.2023.173658_bb0465","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-011-2268-6","article-title":"Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia","volume":"217","author":"Rom\u00f3n","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0470","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"Rosa","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0475","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopha.2018.04.082","article-title":"Pharmacological interaction of Galphimia glauca extract and natural galphimines with ketamine and haloperidol on different behavioral tests","volume":"103","author":"Santill\u00e1n-Urquiza","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbb.2023.173658_bb0480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpsychires.2016.09.017","article-title":"Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs","volume":"84","author":"da Silva Ara\u00fajo","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0485","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuron.2010.02.014","article-title":"A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia","volume":"65","author":"Simpson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2023.173658_bb0490","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pbb.2023.173658_bb0495","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1007\/BF02245011","article-title":"The dopamine-serotonin relationship in clozapine response","volume":"112","author":"Szymanski","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173658_bb0500","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jpsychires.2009.02.005","article-title":"Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders","volume":"43","author":"Thompson","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0505","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0447.1988.tb06312.x","article-title":"Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients","volume":"78","author":"Toru","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pbb.2023.173658_bb0510","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/molecules25051062","article-title":"Is there a future for PPARs in the treatment of neuropsychiatric disorders?","volume":"25","author":"Tufano","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pbb.2023.173658_bb0515","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s12031-022-02046-2","article-title":"Astrocyte activation, but not microglia, is associated with the experimental mouse model of schizophrenia induced by chronic ketamine","volume":"72","author":"Wei","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pbb.2023.173658_bb0520","first-page":"1","article-title":"Repeated dosing of ketamine in the forced swim test: are multiple shots better than one?","volume":"12","author":"Weston","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pbb.2023.173658_bb0525","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pbb.2018.06.003","article-title":"Neurochemical changes underlying schizophrenia-related behavior in a modified forced swim test in mice","volume":"172","author":"Wo\u017aniak","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173658_bb0530","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12264-020-00507-5","article-title":"Probing for conditioned hallucinations through neural activation in a ketamine mouse model of schizophrenia","volume":"36","author":"Wu","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.pbb.2023.173658_bb0535","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2014.12.012","article-title":"Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia","volume":"61","author":"Xu","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2023.173658_bb0540","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pharep.2018.01.001","article-title":"Protective effects of stigmasterol against ketamine-induced psychotic symptoms: possible behavioral, biochemical and histopathological changes in mice","volume":"70","author":"Yadav","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pbb.2023.173658_bb0545","article-title":"The forced swim test as a model of depressive-like behavior","volume":"2015","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2023.173658_bb0550","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1523\/JNEUROSCI.6158-09.2010","article-title":"GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression","volume":"30","author":"Yoon","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2023.173658_bb0555","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173658_bb0560","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.171.12.6827","article-title":"Peroxisome proliferator activator receptor-\u03b3 ligands, 15-deoxy-\u039412,14-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways","volume":"171","author":"Zingarelli","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.pbb.2023.173658_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/neu.2013.31","article-title":"Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia","volume":"26","author":"Zugno","year":"2014","journal-title":"Acta Neuropsychiatr."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T11:33:11Z","timestamp":1736335991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305723001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":113,"alternative-id":["S0091305723001454"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173658","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-\u03b3","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173658"}}